Immunoglobulin (Ig) M antibody against myelin associated glycoprotein (MAG): A comparison of methods.
The presence of immunoglobulin (Ig)M antibody against myelin associated glycoprotein (MAG) has been associated with autoimmune demyelinating, sensorimotor neuropathies. Approximately 50% of patients with IgM paraproteinemia and associated peripheral neuropathy possess antibodies against MAG. These autoantibodies are thought to interfere with the process of myelination, myelin maintenance, or axon-Schwann cell interaction. The detection of these autoantibodies is useful to the clinician and is suggestive of active demyelination in a peripheral neuropathy. Our objective in this study was to compare the results obtained using three different methods (dual enzyme immunoassay [EIA], immunofluorescent antibody [IFA] and Western blot [WB]) for detecting IgM antibody against MAG in patients suspected of having autoimmune demyelinating neuropathies. Since the dual EIA utilized two different antigens, results from this assay were separated into two groups: MAG and sulfate-3-glucuronyl paragloboside (SGPG). When compared to WB (gold standard), percent agreement, sensitivity, and specificity for EIA and IFA are as follows: MAG EIA (68.3, 100.0, and 60.6); SGPG EIA (95.1, 100.0, and 93.9); and myelin IFA (97.6, 100.0, and 97.0). The authors conclude that the SGPG EIA and myelin IFA compared well with the standard WB method when detecting IgM antibody against MAG (100 kD). Many sera demonstrated reactivity on the MAG EIA that were negative by WB (100 kD glycoprotein). The authors recommend screening for MAG IgM in suspected patient sera by SGPG EIA or myelin IFA and utilizing these same methods to titer sera confirmed positive by WB.
Jaskowski
T D
TD
Associated Regional and University Pathologists (ARUP) Institute for Clinical and Experimental Pathology, Salt Lake City, Utah 84108, USA. jaskowtd@aruplab.com
Martins
T B
TB
Litwin
C M
CM
Hill
H R
HR
D001323:Autoantibodies / Q000097:blood*; D015153:Blotting, Western / Q000379:methods; D019084:Fluorescent Antibody Technique, Indirect / Q000379:methods; D005915:Globosides / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods; D007075:Immunoglobulin M / Q000097:blood*; D018992:Myelin-Associated Glycoprotein / Q000276:immunology*; D011129:Polyradiculoneuropathy / Q000276:immunology*
D001323:Autoantibodies; D005915:Globosides; D007075:Immunoglobulin M; D018992:Myelin-Associated Glycoprotein; C051917:sulfate-3-glucuronyl paragloboside